{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:21:53Z","timestamp":1767853313831,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.contraception.2009.07.003","type":"journal-article","created":{"date-parts":[[2009,9,4]],"date-time":"2009-09-04T10:27:33Z","timestamp":1252060053000},"page":"41-48","source":"Crossref","is-referenced-by-count":26,"title":["The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol"],"prefix":"10.1016","volume":"81","author":[{"given":"Robin","family":"Kroll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen Z.","family":"Reape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marya","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.07.003_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2105\/AJPH.81.1.90","article-title":"Trends in the content and use of oral contraceptives in the United States, 1964\u201388","volume":"81","author":"Gerstman","year":"1991","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2009.07.003_bib2","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.003_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2009.07.003_bib4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.07.003_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2004.09.005","article-title":"Twenty micrograms vs. >20 mcg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials","volume":"71","author":"Gallo","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/er.18.1.71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2009.07.003_bib7","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0002-9378(98)70292-3","article-title":"Ovarian activity in women taking an oral contraceptive containing 20 mcg ethinyl estradiol and 150 mcg desogestrel: effects of low estrogen doses during the hormone-free interval","volume":"179","author":"Killick","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.003_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0010-7824(96)00183-7","article-title":"Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.003_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/gye.17.2.107.114","article-title":"A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use","volume":"17","author":"Endrikat","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2009.07.003_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2007.09.010","article-title":"Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive","volume":"77","author":"Reape","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","article-title":"Evaluation of pituitary\u2013ovarian axis suppression with three oral contraceptive regimens","volume":"77","author":"Vandever","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","article-title":"Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen","volume":"78","author":"Klipping","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","article-title":"Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 microg (Loestrin 24 Fe)","volume":"75","author":"Nakajima","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: Phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib17","series-title":"Current US Prescribing Information","author":"Ortho Tri Cyclen\u00ae Lo","year":"2004"},{"key":"10.1016\/j.contraception.2009.07.003_bib18","author":"FDA Advisory Committee for Reproductive Health Drugs"},{"key":"10.1016\/j.contraception.2009.07.003_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","article-title":"Body mass index, weight, and oral contraceptive failure risk","volume":"105","author":"Holt","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.003_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0029-7844(02)01939-7","article-title":"Body weight and risk of oral contraceptive failure","volume":"99","author":"Holt","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.003_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2004.10.009","article-title":"The role of body weight in oral contraceptive failure: results from the 1995 National Survey of Family Growth","volume":"15","author":"Brunner","year":"2005","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.contraception.2009.07.003_bib22","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"Am J of Epidemiol"},{"key":"10.1016\/j.contraception.2009.07.003_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annepidem.2006.01.001","article-title":"Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina","volume":"16","author":"Brunner Huber","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.contraception.2009.07.003_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0010-7824(03)00069-6","article-title":"Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol","volume":"67","author":"LaGuardia","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.003_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2007.11.006","article-title":"Endometrial effects of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo","volume":"77","author":"Anderson","year":"2008","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T10:28:03Z","timestamp":1545042483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409003485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0010782409003485"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.07.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}